[NYPost] President Trump on Tuesday will announce a prescription plan drastically reducing the cost of insulin for American seniors who rely on Medicare.
The deal struck with the nation’s insulin manufacturers and health care providers will limit the co-pay for a month’s supply of insulin to $35 — a 66 percent reduction to current costs, White House counselor Kellyanne Conway said.
The initiative will apply to the 1 in 3 Medicare enrollees who have diabetes, which is approximately 3 million people.
The plan, effective from January 2021, will save seniors approximately 56 percent or an average of $446 each year in insulin co-pays, said Seema Verma, administrator of the Centers for Medicare and Medicaid Services.
| But is this a cut in total price or just the out-of-pocket cost to patients, a larger balance now being picked up by the government? Either way, the announcement will get the attention of older voters... |
|